3Holst JJ.Glucagon and glucagon-like peptides 1 and 2.Results Probl Cell Diffe,2010,50:121-135.
4Doyle ME,Egan JM.Mechanisms of action of glucagon-like peptide 1 in the pancreas.Pharmacol Ther,2007,113:546-593.
5Baggio LL,Drucker DJ.Biology of incretins:GLP-1 and GIP.Gastroenterology,2007,132:2131-2157.
6Herrmann C,Goke R,Richter G,et al.Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.Digestion,1995,56:117-126.
7Anini Y,Brubaker PL.Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells.Endocrinology,2003,144:3244-3250.
8De Leon DD,Crutchlow MF,Ham JY,et al.Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.Int J Biochem Cell Biol,2006,38:845-859.
9Kim MH,Lee MK.The incretins and pancreatic beta-cells:use of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide to cure type 2 diabetes mellitus.Korean Diabetes J,2010,34:2-9.
10Nauck MA,Heimesaat MM,Behle K,et al.Effects of glucagon-like peptide 1 on counterregulatory hormone responses,cognitive functions,and insulin secretion during hyperinsulinemic,stepped hypoglycemic clamp experiments in healthy volunteers.J Clin Endocrinol Metab,2002,87:1239-1246.
